818-472-5484
    EnglishยทEspaรฑolยทืขื‘ืจื™ืช

    ื”ืื Medicare ืžื›ืกื” ืชืจื•ืคื•ืช ื”ืจื–ื™ื” ื›ืžื• Ozempic ืื• Wegovy?

    ื‘ืื•ืคืŸ ื—ืœืงื™, ื•ื”ื›ืœืœื™ื ื”ืฉืชื ื• ื‘-2026. Medicare ืขื“ื™ื™ืŸ ืื™ื ื” ื™ื›ื•ืœื” ืœื›ืกื•ืช ืชืจื•ืคื•ืช ืฉื ืจืฉืžื•ืช ืืš ื•ืจืง ืœื”ืจื–ื™ื” ืชื—ืช Part D, ืืš ืชื•ื›ื ื™ืช ืคื“ืจืœื™ืช ื—ื“ืฉื” ืฉื”ื—ืœื” ื‘-1 ื‘ื™ื•ืœื™ 2026 ืžืขื ื™ืงื” ืœืžื•ื˜ื‘ื™ื ื–ื›ืื™ื ื’ื™ืฉื” ืœืชืจื•ืคื•ืช GLP-1 ื ื‘ื—ืจื•ืช ืœื”ืจื–ื™ื” ืชืžื•ืจืช ืชืฉืœื•ื ื”ืฉืชืชืคื•ืช ืขืฆืžื™ืช ื—ื•ื“ืฉื™ ืฉืœ 50 ื“ื•ืœืจ. ืœืืจื” ื’ื•ืœืกื•ืŸ ื”ื™ื ืกื•ื›ื ืช ื‘ื™ื˜ื•ื— ืขืฆืžืื™ืช ื•ืžื•ืจืฉื™ืช, ื‘ืขืœืช ืจื™ืฉื™ื•ืŸ ื‘-11 ืžื“ื™ื ื•ืช, ืฉืขื•ื–ืจืช ืœืื ืฉื™ื ืœื”ืชืžืฆื ื‘ืฉื™ื ื•ื™ื™ื ื›ืžื• ื–ื” ืœืœื ืขืœื•ืช, ื‘ืื ื’ืœื™ืช, ื‘ืกืคืจื“ื™ืช ื•ื‘ืขื‘ืจื™ืช. ื”ืชืงืฉืจื• ืœ-818-472-5484 ื›ื“ื™ ืœื‘ื“ื•ืง ื›ื™ืฆื“ ื”ื›ืœืœื™ื ื•ื”ื“ืจื™ืฉื•ืช ื”ื—ื“ืฉื™ื ืœื–ื›ืื•ืช ื—ืœื™ื ืขืœ ืžืฆื‘ื›ื ื”ื‘ืจื™ืื•ืชื™ ื•ืขืœ ื›ื™ืกื•ื™ ืชืจื•ืคื•ืช Part D ื”ื ื•ื›ื—ื™ ืฉืœื›ื.

    ืœืืจื” ื’ื•ืœืกื•ืŸ ื”ื™ื ืกื•ื›ื ืช ื‘ื™ื˜ื•ื— ืขืฆืžืื™ืช ื•ืžื•ืจืฉื™ืช, CA License 0E69969, ืฉืื™ื ื” ืžืงื•ืฉืจืช ืœ-Medicare ืื• ืœื›ืœ ืกื•ื›ื ื•ืช ืžืžืฉืœืชื™ืช ื•ืื™ื ื” ืžืงื‘ืœืช ืžืžื ื” ืชืžื™ื›ื”. ืื ื—ื ื• ืœื ืžืฆื™ืขื™ื ืืช ื›ืœ ื”ืชื•ื›ื ื™ื•ืช ื”ื–ืžื™ื ื•ืช ื‘ืื–ื•ืจื›ื. ืœื›ืœ ื”ืืคืฉืจื•ื™ื•ืช ืฉืœื›ื, ื‘ืงืจื• ื‘ืืชืจ Medicare.gov ืื• ื”ืชืงืฉืจื• ืœ-โ€Ž1-800-MEDICARE.

    Lara Goulson, Licensed Insurance Agent, CA License #0E69969, NPN 8407942

    ื›ื™ืกื•ื™ GLP-1 ื•ืชื•ื›ื ื™ืช ื”ื’ื™ืฉื•ืจ ื”ื—ื“ืฉื” ืฉืœ Medicare

    ืขืœ ืคื™ ื—ื•ืง, ื—ืœืง D ืฉืœ ืžื“ื™ืงืจ ื”ื™ื” ืžื ื•ืข ืฉื ื™ื ืžื›ื™ืกื•ื™ ืชืจื•ืคื•ืช ืฉื ืจืฉืžื• ืœื™ืจื™ื“ื” ื‘ืžืฉืงืœ ื‘ืœื‘ื“. ืœื›ืŸ ืื•ืชื” ืชืจื•ืคื” ื™ื›ื•ืœื” ืœื”ื™ื•ืช ืžื›ื•ืกื” ืœืฉื›ืŸ ืื—ื“ ื•ืœื ืœืื—ืจ: ื›ืฉ-GLP-1 ื›ืžื• ืื•ื–ืžืคื™ืง ื ืจืฉื ืœืกื•ื›ืจืช ืกื•ื’ 2, ื”ื•ื ืขื•ื‘ืจ ื“ืจืš ืชื•ื›ื ื™ืช ื—ืœืง D ื‘ื›ืœืœื™ ื”ืฉืชืชืคื•ืช ืจื’ื™ืœื™ื, ืื‘ืœ ืžืจืฉื ื–ื”ื” ืฉื ื›ืชื‘ ืจืง ืœื™ืจื™ื“ื” ื‘ืžืฉืงืœ ื ืฉืืจ ืžื—ื•ืฅ ืœืžื” ืฉื—ืœืง D ื™ื›ื•ืœ ืœืฉืœื. ืฉื ื™ ื“ื‘ืจื™ื ืžืจื›ื›ื™ื ืืช ื”ื›ืœืœ ื‘-2026. ืจืืฉื™ืช, ืžื“ื™ืงืจ ืžื›ืกื” ื‘-0 ื“ื•ืœืจ ื‘ื“ื™ืงืช ื”ืฉืžื ื” ื•ื™ื™ืขื•ืฅ ื”ืชื ื”ื’ื•ืชื™ ืžืจื•ืคื ืจืืฉื•ื ื™ ืœืžื™ ืฉืžื“ื“ ืžืกืช ื”ื’ื•ืฃ ืฉืœื• 30 ื•ืžืขืœื”. ืฉื ื™ืช, ืชื•ื›ื ื™ืช ืžื“ื™ืงืจ ื—ื“ืฉื” ืฉื”ื—ืœื” ื‘-1 ื‘ื™ื•ืœื™ 2026 ืžืฆื™ืขื” ืชืจื•ืคื•ืช GLP-1 ืžื›ื•ืกื•ืช ืœื™ืจื™ื“ื” ื‘ืžืฉืงืœ ื‘ืชืฉืœื•ื ื—ื•ื“ืฉื™ ืฉืœ 50 ื“ื•ืœืจ ืœื–ื›ืื™ื ืขื ื—ืœืง D. ื”ืื ืืชื ื–ื›ืื™ื, ื•ืื™ืœื• ืชืจื•ืคื•ืช ื”ืชื•ื›ื ื™ืช ื›ื•ืœืœืช, ื–ื” ื‘ื“ื™ื•ืง ืžื” ืฉืื ื—ื ื• ืžืืžืชื™ื ืžื•ืœ ื”ืชื•ื›ื ื™ืช ืœืคื ื™ ืฉืžืฉืœืžื™ื ืžื—ื™ืจ ืžืœื.

    ืžื™ ื–ื›ืื™ ืœืชื•ื›ื ื™ืช ื‘-50 ื“ื•ืœืจ, ื•ืžื” 50 ื”ื“ื•ืœืจ ืœื ืขื•ืฉื™ื

    ื”ืชื•ื›ื ื™ืช ื”ื–ืืช ืžื™ื•ืขื“ืช ืจืง ืœืžื™ ืฉื›ื‘ืจ ื™ืฉ ืœื• ื›ื™ืกื•ื™ ืชืจื•ืคื•ืช ืฉืœ ืžื“ื™ืงืจ, ื›ื•ืœืœ ืชื•ื›ื ื™ืช ืชืจื•ืคื•ืช ืขืฆืžืื™ืช ืฉืœ ืžื“ื™ืงืจ, ืชื•ื›ื ื™ืช Medicare Advantage ืœื˜ื™ืคื•ืœ ืžืชื•ืื ืขื ื›ื™ืกื•ื™ ืชืจื•ืคื•ืช, ืชื•ื›ื ื™ืช ืœืฆืจื›ื™ื ืžื™ื•ื—ื“ื™ื, ืชื•ื›ื ื™ืช ืงื‘ื•ืฆืชื™ืช ืฉืœ ืžืขืกื™ืง ืื• ืฉืœ ืื™ื’ื•ื“ ืขื•ื‘ื“ื™ื ืขื ื•ื™ืชื•ืจ, ื•ืชื•ื›ื ื™ืช ื”ืžืขื‘ืจ ืœื–ื›ืื™ื ื—ื“ืฉื™ื ื‘ืขืœื™ ื”ื›ื ืกื” ืžื•ื’ื‘ืœืช. ืื ื™ืฉ ืœื›ื ืžื“ื™ืงืจ ืžืงื•ืจื™ ื‘ืœื™ ืฉื•ื ืชื•ื›ื ื™ืช ืชืจื•ืคื•ืช, ืฉื•ื ืขืจืš ืฉืœ ืžื“ื“ ืžืกืช ื”ื’ื•ืฃ ืœื ื™ื–ื›ื” ืืชื›ื, ืืš ืžื“ื™ืงืจ ื›ืŸ ืžืืคืฉืจืช ืœื”ืฆื˜ืจืฃ ืœืชื•ื›ื ื™ืช ืชืจื•ืคื•ืช ื‘ืชืงื•ืคื•ืช ืžืกื•ื™ืžื•ืช, ื•ื–ื” ื™ื—ื–ื™ืจ ืืช ื”ืชื•ื›ื ื™ืช ื”ื–ืืช ืœื”ื™ืฉื’ ื™ื“ื›ื. ื’ื ืขื ื”ื›ื™ืกื•ื™ ื”ื–ื” ืื™ื ื›ื ื–ื›ืื™ื ืื ืืชื ื›ื‘ืจ ืžืงื‘ืœื™ื ืชืจื•ืคื•ืช GLP-1 ื“ืจืš ืชื•ื›ื ื™ืช ื”-Part D ืฉืœื›ื, ื•ื’ื ืœื ืื ื™ืฉ ืœื›ื ืกื•ื›ืจืช ืžืกื•ื’ 2, ื“ื•ื ื ืฉื™ืžื” ื‘ืฉื™ื ื” ื‘ืจืžื” ื‘ื™ื ื•ื ื™ืช ืขื“ ื—ืžื•ืจื” ืื• ื›ื‘ื“ ืฉื•ืžื ื™, ืื ื›ื™ ืขื ืฉืœื•ืฉืช ื”ืื‘ื—ื•ื ื™ื ื”ืืœื” ื™ื™ืชื›ืŸ ืฉืชื•ื›ื ื™ืช ื”-Part D ืฉืœื›ื ืขื“ื™ื™ืŸ ืชื›ืกื” ืœื›ื ืืช ืชืจื•ืคื•ืช ื”-GLP-1. ืžืขื‘ืจ ืœื›ืš ืขืœื™ื›ื ืœื”ื™ื•ืช ื‘ื ื™ 18 ื•ืžืขืœื” ื•ืœืขืžื•ื“ ื‘ืื—ื“ ืžืฉืœื•ืฉื” ืชื ืื™ื ื‘ืžื•ืขื“ ืชื—ื™ืœืช ื”ื˜ื™ืคื•ืœ ื‘-GLP-1: ืžื“ื“ ืžืกืช ื’ื•ืฃ ืฉืœ 35 ื•ืžืขืœื”; ืžื“ื“ ืžืกืช ื’ื•ืฃ ืฉืœ 30 ื•ืžืขืœื” ื™ื—ื“ ืขื ืื™ ืกืคื™ืงืช ืœื‘ ื“ื™ืืกื˜ื•ืœื™ืช, ืœื—ืฅ ื“ื ื’ื‘ื•ื” ืฉืื™ื ื• ืžืื•ื–ืŸ ืื• ืžื—ืœืช ื›ืœื™ื•ืช ื›ืจื•ื ื™ืช ื‘ืฉืœื‘ 3a ื•ืžืขืœื”; ืื• ืžื“ื“ ืžืกืช ื’ื•ืฃ ืฉืœ 27 ื•ืžืขืœื” ื™ื—ื“ ืขื ื˜ืจื•ื ืกื•ื›ืจืช, ื”ืชืงืฃ ืœื‘ ืื• ืฉื‘ืฅ ื‘ืขื‘ืจ, ืื• ืžื—ืœืช ืขื•ืจืงื™ื ื”ื™ืงืคื™ืช ืขื ืชืกืžื™ื ื™ื. ื”ืชืจื•ืคื•ืช ื”ืžื›ื•ืกื•ืช ื”ืŸ Foundayo ื‘ื˜ื‘ืœื™ื•ืช, Wegovy ื‘ื”ื–ืจืงื” ืื• ื‘ื˜ื‘ืœื™ื”, ื•-Zepbound ื‘ืขื˜ KwikPen ื‘ืœื‘ื“, ื•ืœื ื‘ื‘ืงื‘ื•ืงื•ื ื™ื ืื• ื‘ืขื˜ื™ื ืฉืœ ืžื ื” ื‘ื•ื“ื“ืช. ืœืื—ืจ ืฉื”ืื™ืฉื•ืจ ื”ืžื•ืงื“ื ืฉืœื›ื ืžืื•ืฉืจ, ื”ื•ื ืชืงืฃ ืขื“ 31 ื‘ื“ืฆืžื‘ืจ 2027, ื›ื•ืœืœ ืžืจืฉืžื™ื ื—ื•ื–ืจื™ื ื•ืฉื™ื ื•ื™ื™ ืžื™ื ื•ืŸ, ืืœื ืื ืชื—ืœื™ืคื• ืชืจื•ืคืช GLP-1. 50 ื”ื“ื•ืœืจ ื”ืืœื” ืื™ื ื ื ื—ืฉื‘ื™ื ืœืฆื•ืจืš ื”ื”ืฉืชืชืคื•ืช ื”ืขืฆืžื™ืช ื”ืฉื ืชื™ืช ืฉืœ ืชื•ื›ื ื™ืช ื”ืชืจื•ืคื•ืช ืฉืœื›ื ื•ืœื ืœืฆื•ืจืš ืชืงืจืช ื”ื”ื•ืฆืื•ืช ื”ืฉื ืชื™ืช ืžื”ื›ื™ืก, ื•ื”ื ืœืขื•ืœื ืื™ื ื ืžื•ืคื™ืขื™ื ื‘ื”ืกื‘ืจ ื”ื”ื˜ื‘ื•ืช ืฉืœ ื”-Part D ืฉืœื›ื. ื”ืื ื”ืชื•ื›ื ื™ืช ืฉืœื›ื ืžื›ื ื™ืกื” ืืชื›ื ืœืชื•ื›ื ื™ืช ื”ื–ืืช ืื• ืžืฉืื™ืจื” ืืชื›ื ื‘ื—ื•ืฅ? ื”ืชืงืฉืจื• ืœืœืืจื” ื‘ืžืกืคืจ 818-472-5484 ื•ื’ืœื•.

    ืžื” ื›ืœืœื™ 2026 ื‘ืืžืช ืขื•ืœื™ื ืœื›ื

    ื”ื ืชื•ืŸ ื”ื™ื—ื™ื“ ืฉ-Medicare.gov ืžืคืจืกืžืช ืœืชื•ื›ื ื™ืช ื”ื™ืจื™ื“ื” ื‘ืžืฉืงืœ ื”ื—ื“ืฉื” ื”ื•ื ืชืฉืœื•ื ืฉืœ 50 ื“ื•ืœืจ ืœืืกืคืงื” ื—ื•ื“ืฉื™ืช ืฉืœ ืชืจื•ืคื•ืช GLP-1 ืžื›ื•ืกื•ืช, ื–ืžื™ืŸ ืž-1 ื‘ื™ื•ืœื™ 2026 ืœื–ื›ืื™ื ืขื ื›ื™ืกื•ื™ ื—ืœืง D. ื›ืœ ื”ืฉืืจ ืชืœื•ื™ ื‘ืกื™ื‘ืช ื”ืžืจืฉื, ื•ื”ื˜ื‘ืœื” ืœืžื˜ื” ืžืคืจื˜ืช. ืคืจื˜ื™ ื”ื–ื›ืื•ืช ืœืชื•ื›ื ื™ืช ื”ื—ื“ืฉื” ืžื’ื™ืขื™ื ืžืชื•ื›ื ื™ืช ื—ืœืง D ืฉืœื›ื, ื•ืื ื—ื ื• ื‘ื•ื“ืงื™ื ืื•ืชื ืืชื›ื ืœืœื ืขืœื•ืช.

    ืžืฆื‘ืžื” ืžืฉืœืžื™ื
    ืชืจื•ืคื•ืช GLP-1 ืœื™ืจื™ื“ื” ื‘ืžืฉืงืœ ื“ืจืš ืชื•ื›ื ื™ืช ืžื“ื™ืงืจ ื”ื—ื“ืฉื” ืฉื”ื—ืœื” ื‘-1 ื‘ื™ื•ืœื™ 2026, ืœื–ื›ืื™ื ืขื ื—ืœืง Dืชืฉืœื•ื ืฉืœ 50 ื“ื•ืœืจ ืœืืกืคืงื” ื—ื•ื“ืฉื™ืช
    ืื•ื–ืžืคื™ืง ื‘ืžืจืฉื ืœืกื•ื›ืจืช ืกื•ื’ 2 ื“ืจืš ืชื•ื›ื ื™ืช ื—ืœืง Dื”ื”ืฉืชืชืคื•ืช ื”ืจื’ื™ืœื” ืฉืœ ื”ืชื•ื›ื ื™ืช, ืฉื ืกืคืจืช ืœืชืงืจืช 2,100 ื”ื“ื•ืœืจ ืฉืœ ื—ืœืง D ื‘-2026
    ื‘ื“ื™ืงืช ื”ืฉืžื ื” ื•ื™ื™ืขื•ืฅ ื”ืชื ื”ื’ื•ืชื™ ืžืจื•ืคื ืจืืฉื•ื ื™, ืœ-BMI ืฉืœ 30 ื•ืžืขืœื”0 ื“ื•ืœืจ ืื ื”ืกืคืง ืžืงื‘ืœ ืืช ื”ื”ืงืฆืื”
    ืžืจืฉื GLP-1 ืฉื ื›ืชื‘ ืœื™ืจื™ื“ื” ื‘ืžืฉืงืœ ื‘ืœื‘ื“, ืžื—ื•ืฅ ืœืชื•ื›ื ื™ืช ื”ื—ื“ืฉื”ืžื—ื™ืจ ืžืœื, ื—ืœืง D ืื™ื ื• ื™ื›ื•ืœ ืœื›ืกื•ืช

    ืžืงื•ืจ: Medicare.gov, ืขืžื•ื“ ื›ื™ืกื•ื™ ื˜ื™ืคื•ืœ ื”ืชื ื”ื’ื•ืชื™ ื‘ื”ืฉืžื ื”, ืื•ืžืช ื‘ืกืคื˜ืžื‘ืจ 2026. ืชืงืจืช ื—ืœืง D ื‘-2026 ื”ื™ื 2,100 ื“ื•ืœืจ.

    Original Medicare ืžื•ืœ Medicare Advantage

    ืžื›ื™ื•ื•ืŸ ืฉื›ื™ืกื•ื™ ื”ืจื–ื™ื” ืžืกื•ื’ GLP-1 ืขื•ื‘ืจ ื“ืจืš ื”ื˜ื‘ื•ืช ื”ืชืจื•ืคื•ืช ืฉืœ Part D ื•ืœื ื”ื˜ื‘ื•ืช ืจืคื•ืื™ื•ืช ืฉืœ Part B, ื”ื”ื‘ื—ื ื” ื”ื—ืฉื•ื‘ื” ื‘ื™ื•ืชืจ ื›ืืŸ ื”ื™ื ื”ืื ื™ืฉ ืœื›ื ื‘ื›ืœืœ ื›ื™ืกื•ื™ ืชืจื•ืคื•ืช Part D, ื‘ื™ืŸ ืื ื“ืจืš ืชื•ื›ื ื™ืช ืขืฆืžืื™ืช ืื• ื“ืจืš ืชื•ื›ื ื™ืช Medicare Advantage ื”ื›ื•ืœืœืช ื›ื™ืกื•ื™ ืชืจื•ืคื•ืช. ืชื•ื›ื ื™ื•ืช Medicare Advantage ืขื ื›ื™ืกื•ื™ ืชืจื•ืคื•ืช ืคื•ืขืœื•ืช ืœืคื™ ืื•ืชื ื›ืœืœื™ Part D ืขื‘ื•ืจ ืชืจื•ืคื•ืช GLP-1, ื›ื•ืœืœ ื–ื›ืื•ืช ืœืชื•ื›ื ื™ืช ื”-GLP-1 Bridge ื”ื—ื“ืฉื” ื•ื›ื™ืกื•ื™ ืœืื™ื ื“ื™ืงืฆื™ื•ืช ืฉืœ ืกื•ื›ืจืช ืื• ืงืจื“ื™ื•ื•ืกืงื•ืœืจื™ื•ืช. ืœื—ืœืง ืžืชื•ื›ื ื™ื•ืช Medicare Advantage ืขืฉื•ื™ื™ื ืœื”ื™ื•ืช ืžื™ืงื•ื ืฉื•ื ื” ื‘ืจืฉื™ืžืช ื”ืชืจื•ืคื•ืช ื•ืฉืœื‘ื™ ืื™ืฉื•ืจ ืžื•ืงื“ื ืžืฉืœื”ืŸ ืขื‘ื•ืจ ืชืจื•ืคื•ืช ืืœื”, ื•ืœื›ืŸ ื›ื“ืื™ ืœื‘ื“ื•ืง ื›ื™ืฆื“ ื”ืชื•ื›ื ื™ืช ื”ืกืคืฆื™ืคื™ืช ืฉืœื›ื ืžืชืžื•ื“ื“ืช ืขื Ozempic, Wegovy ืื• ืชืจื•ืคื•ืช ื“ื•ืžื•ืช ืœืคื ื™ ืฉืžื ื™ื—ื™ื ืฉื™ืฉ ื›ื™ืกื•ื™. ืื ืืชื ืฉื•ืงืœื™ื ืœืขื‘ื•ืจ ืชื•ื›ื ื™ืช ื‘ืžื™ื•ื—ื“ ื›ื“ื™ ืœืงื‘ืœ ื’ื™ืฉื” ื˜ื•ื‘ื” ื™ื•ืชืจ ืœ-GLP-1, ื”ืฉื•ื• ืืช ืจืฉื™ืžื•ืช ื”ืชืจื•ืคื•ืช ื‘ืงืคื™ื“ื”, ืฉื›ืŸ ื”ื›ื™ืกื•ื™ ืœืชืจื•ืคื•ืช ืืœื” ื•ื›ืœ ืฉืœื‘ื™ ื”ืื™ืฉื•ืจ ื”ืžื•ืงื“ื ื™ื›ื•ืœื™ื ืœื”ื™ื•ืช ืฉื•ื ื™ื ืžืฉืžืขื•ืชื™ืช ืืคื™ืœื• ื‘ื™ืŸ ืชื•ื›ื ื™ื•ืช Medicare Advantage ื”ืžื•ืฆืขื•ืช ื‘ืื•ืชื” ืžื—ื•ื–ื”.

    ื‘ื“ืงื• ืืช ื–ื›ืื•ืชื›ื ืœ-GLP-1

    ื”ื–ื›ืื•ืช ื•ื”ื ื™ื™ืจืช ืขื‘ื•ืจ ื”-GLP-1 Bridge ืขื•ื‘ืจื•ืช ื“ืจืš ื”ืจื•ืคื ืฉืœื›ื ื•ื“ืจืš ื”ื”ืจืฉืžื” ืฉืœื›ื ืœ-Part D, ื•ืœื›ืŸ ื›ื“ืื™ ืœื•ื•ื“ื ืฉืืชื ืื›ืŸ ืจืฉื•ืžื™ื ืœื›ื™ืกื•ื™ ืชืจื•ืคื•ืช Part D ืœืคื ื™ ืฉืืชื ืคื•ื ื™ื ืœื›ืš. ืกื•ื›ื ืช ืžื•ืจืฉื™ืช ื™ื›ื•ืœื” ื’ื ืœื‘ื“ื•ืง ื›ื™ืฆื“ ื”ืชื•ื›ื ื™ืช ื”ื ื•ื›ื—ื™ืช ืฉืœื›ื ืžืชืžื•ื“ื“ืช ืขื ืชืจื•ืคื•ืช GLP-1 ืฉื ืจืฉืžื•ืช ืœืกื•ื›ืจืช ืื• ืœืžื—ืœืช ืœื‘, ื•ืœื•ื•ื“ื ืฉืืชื ืžื‘ื™ื ื™ื ืืช ืงืจื™ื˜ืจื™ื•ื ื™ ื”-BMI ื•ืฉืœื‘ื™ ื”ืื™ืฉื•ืจ ื”ืžื•ืงื“ื ืœืคื ื™ ืฉืžื’ื™ืข ื—ืœื•ืŸ ื”ื”ืจืฉืžื” ื”ื‘ื ืฉืœื›ื.

    ื”ืชืงืฉืจื• ืœ-818-472-5484 ื›ื“ื™ ืœื‘ืจืจ ืื ืืชื ื–ื›ืื™ื ืœืชื•ื›ื ื™ืช ื”-GLP-1 Bridge ื”ื—ื“ืฉื”.

    ื‘ืขืœืช ืจื™ืฉื™ื•ืŸ ื‘-11 ืžื“ื™ื ื•ืช ยท ื“ื™ืจื•ื’ 5.0 ื‘ื’ื•ื’ืœ ยท ืœืœื ืขืœื•ืช ืขื‘ื•ืจืš

    ืฉืืœื•ืช ื ืคื•ืฆื•ืช

    ืขื‘ื•ืจ ืžื•ื˜ื‘ื™ื ื”ืขื•ืžื“ื™ื ื‘ืงืจื™ื˜ืจื™ื•ื ื™ื ืฉืœ ื”-Medicare GLP-1 Bridge, Wegovy ืขื•ืœื” 50 ื“ื•ืœืจ ืœื—ื•ื“ืฉ ืขื‘ื•ืจ ืืกืคืงื” ืœ-30 ื™ื•ื, ืž-1 ื‘ื™ื•ืœื™ 2026 ื•ืขื“ ืกื•ืฃ 2027, ื‘ื›ืคื•ืฃ ืœืื™ืฉื•ืจ ืžืจืืฉ. ืžื—ื•ืฅ ืœืชื•ื›ื ื™ืช ื”ื’ื™ืฉื•ืจ, Part D ื™ื›ื•ืœื” ืœื›ืกื•ืช Wegovy ืจืง ืขื‘ื•ืจ ื”ืื™ื ื“ื™ืงืฆื™ื” ื”ืงืจื“ื™ื•ื•ืกืงื•ืœืจื™ืช ืฉืœื”, ื‘ื›ืคื•ืฃ ืœื”ืฉืชืชืคื•ืช ื”ืขืฆืžื™ืช ื”ืจื’ื™ืœื” ืฉืœ ื”ืชื•ื›ื ื™ืช ืฉืœื›ื.

    ื›ืŸ, ืขื‘ื•ืจ ืกื•ื›ืจืช ืžืกื•ื’ 2. ืชื•ื›ื ื™ื•ืช Part D ืžื›ืกื•ืช Ozempic ื›ืืฉืจ ื”ื•ื ื ืจืฉื ืœืกื•ื›ืจืช, ื‘ื›ืคื•ืฃ ืœืจืฉื™ืžืช ื”ืชืจื•ืคื•ืช ื•ืœื”ืฉืชืชืคื•ืช ื”ืขืฆืžื™ืช ืฉืœ ื”ืชื•ื›ื ื™ืช. Ozempic ืฉื ืจืฉื ืจืง ืœื”ืจื–ื™ื” ืื™ื ื• ืžื›ื•ืกื”, ื•-Ozempic ืื™ื ื• ื ื›ืœืœ ื‘ืจืฉื™ืžืช ื”ืชืจื•ืคื•ืช ืฉืœ ืชื•ื›ื ื™ืช ื”-GLP-1 Bridge.

    ืงื‘ืœื• ื‘ื“ื™ืงืช ืชื•ื›ื ื™ืช ื—ื™ื ื

    ืฉืœื—ื• ืœืœืืจื” ื’ื•ืœืกื•ืŸ ืืช ืฉืืœืชื›ื ื‘ื ื•ื’ืข ืœื›ื™ืกื•ื™ ืชืจื•ืคื•ืช GLP-1 ืื• ื”ืจื–ื™ื” ื•ืงื‘ืœื• ืชืฉื•ื‘ื” ื‘ืจื•ืจื” ืœืœื ืขืœื•ืช.

    ื‘ืฉืœื™ื—ืช ื”ื˜ื•ืคืก ื”ื–ื” ืืชื ืžืกื›ื™ืžื™ื ืฉืกื•ื›ืŸ ื‘ื™ื˜ื•ื— ืžื•ืจืฉื” ื™ื•ื›ืœ ืœื™ืฆื•ืจ ืืชื›ื ืงืฉืจ ื‘ื˜ืœืคื•ืŸ, ื‘ืื™ืžื™ื™ืœ ืื• ื‘ื”ื•ื“ืขืช ื˜ืงืกื˜ ื‘ื ื•ื’ืข ืœืืคืฉืจื•ื™ื•ืช ื”ื‘ื™ื˜ื•ื— ืฉืœื›ื.

    ื‘ืขืœืช ืจื™ืฉื™ื•ืŸ ื‘-11 ืžื“ื™ื ื•ืช ยท ื“ื™ืจื•ื’ 5.0 ื‘ื’ื•ื’ืœ ยท ืœืœื ืขืœื•ืช ืขื‘ื•ืจืš

    ืื™ื ื ื• ืžืฆื™ืขื™ื ื›ืœ ืชื•ื›ื ื™ืช ื”ื–ืžื™ื ื” ื‘ืื–ื•ืจื›ื. ื›ื™ื•ื ืื ื• ืžื™ื™ืฆื’ื™ื 18 ืืจื’ื•ื ื™ื ื”ืžืฆื™ืขื™ื 233 ืžื•ืฆืจื™ื ื‘ืื–ื•ืจื›ื. ืื ื ืคื ื• ืืœ Medicare.gov ืื• โ€Ž1-800-MEDICARE ื›ื“ื™ ืœืงื‘ืœ ืžื™ื“ืข ืขืœ ื›ืœ ื”ืืคืฉืจื•ื™ื•ืช ืฉืœื›ื. ืื™ื ื ื• ืงืฉื•ืจื™ื ืœืžืžืฉืœืช ืืจืฆื•ืช ื”ื‘ืจื™ืช ืื• ืœืชื•ื›ื ื™ืช ื”ืžื“ื™ืงืจ ื”ืคื“ืจืœื™ืช ื•ืื™ื ื ื• ื ืชืžื›ื™ื ืขืœ ื™ื“ืŸ. ืืชืจ ื–ื” ืžื”ื•ื•ื” ื”ืฆืขื” ืœืจื›ื™ืฉืช ื‘ื™ื˜ื•ื—. Goulson Insurance Services Inc., ืจื™ืฉื™ื•ืŸ ืชืื’ื™ื“ ืงืœื™ืคื•ืจื ื™ื” #6020069. ืœืืจื” ื’ื•ืœืกื•ืŸ, ืจื™ืฉื™ื•ืŸ ืงืœื™ืคื•ืจื ื™ื” #0E69969, NPN 8407942.

    ืื™ื ื ื• ืžืฆื™ืขื™ื ื›ืœ ืชื•ื›ื ื™ืช ื”ื–ืžื™ื ื” ื‘ืื–ื•ืจื›ื. ื›ื™ื•ื ืื ื• ืžื™ื™ืฆื’ื™ื 18 ืืจื’ื•ื ื™ื ื”ืžืฆื™ืขื™ื 233 ืžื•ืฆืจื™ื ื‘ืื–ื•ืจื›ื. ืื ื ืคื ื• ืืœ Medicare.gov ืื• โ€Ž1-800-MEDICARE ื›ื“ื™ ืœืงื‘ืœ ืžื™ื“ืข ืขืœ ื›ืœ ื”ืืคืฉืจื•ื™ื•ืช ืฉืœื›ื. Goulson Insurance Services ืื™ื ื” ืžืกื•ื ืคืช ืœืžื“ื™ืงืจ ืื• ืœื›ืœ ื’ื•ืฃ ืžืžืฉืœืชื™ ื•ืื™ื ื” ืžืงื‘ืœืช ืžื”ื ื—ืกื•ืช.